Abstract
Abstract The activities of the Committee on Drugs during the past year have included the clinical evaluation of prednisone (Meticorten) and prednisolone (Meticortelone), phenyltoloxamine-resin complex (Histionex), bronchodilator JB-251, zinc-ACTH, and gamma globulin. In addition, the Committee has furnished advisory services to the Food and Drug Administration, physicians, pharmaceutical manufacturers, and the public regarding drugs used in the treatment of allergy, as well as assistance in the investigation of unsubstantiated claims for drug treatment of allergic states.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
